NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-CA-21-013 from the NIH Guide for Grants and Contracts
Notice NOT-CA-21-012 from the NIH Guide for Grants and Contracts
Notice NOT-CA-21-011 from the NIH Guide for Grants and Contracts
Notice NOT-CA-21-010 from the NIH Guide for Grants and Contracts
Notice NOT-CA-21-008 from the NIH Guide for Grants and Contracts
Notice NOT-AA-20-023 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-GM-21-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications to strengthen the regional technology transfer accelerator hubs for Institutional Development Award (IDeA) states. Accelerator hubs funded by the awards under this FOA are expected to develop, refine, and implement comprehensive programs for fostering biomedical entrepreneurship which will promote technology transfer, small business finance and management, and other business skills needed to move basic discoveries and technologies out of the lab into commercial products that improve patient care and enhance human health. Each Hub will serve a network of multiple institutional sites across the IDeA states in one of the four regions where the academic partners are located. The goals of this FOA are to: 1) build on regional technology transfer programs to further strengthen the capacity to bring scientific results from academic institutions into the market; 2) fund a pilot project program for product definition studies (e.g., feasibility studies, prototype development, proof-of-concept, and preclinical studies); 3) provide access to expertise and resources in areas required for early stage technology development; 4) provide skills development and hands-on experience in entrepreneurship; and 5) promote a sustainable culture of biomedical entrepreneurship within IDeA states. It is anticipated that the educational tools developed under this FOA will be licensed or sold to other institutions that wish to create accelerator hubs. Establishing public-private partnerships and securing additional non-federal funds will be critical for long-term success.
Notice NOT-OD-21-010 from the NIH Guide for Grants and Contracts
Notice NOT-MH-21-065 from the NIH Guide for Grants and Contracts
Notice NOT-OH-21-007 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-013 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-014 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-015 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-016 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-018 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-012 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-20-236 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research.
Funding Opportunity PA-21-052 from the NIH Guide for Grants and Contracts. The purpose of this Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research award is to enhance the diversity of the health-related research workforce by supporting the research training of predoctoral students from diverse backgrounds including those from groups that are underrepresented in the biomedical, behavioral, or clinical research workforce. Through this award program, promising predoctoral students will obtain individualized, mentored research training from outstanding faculty sponsors while conducting well-defined research projects in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training is expected to clearly enhance the individual's potential to develop into a productive, independent research scientist. This Funding Opportunity Announcement (FOA) does not allow candidates to propose to lead an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.
Funding Opportunity RFA-NS-21-008 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement invites applications from experienced investigators seeking to conduct exploratory clinical trials designed to test new treatments for patients with Lewy Body Dementia (LBD). Applicants may propose to conduct either Phase I or Phase II clinical trials depending on the developmental stage of the potential therapeutic, but all trials must include patients with LBD. Proposed therapies may include novel medications or devices, or existing treatments that are potentially beneficial but not currently approved for use in patients with LBD. Treatments intended to prevent or delay disease progression in LBD patients, as well as therapies to alleviate existing motor or non-motor clinical symptoms, are of interest.
Notice NOT-LM-21-001 from the NIH Guide for Grants and Contracts